Sat.Feb 04, 2023 - Fri.Feb 10, 2023

article thumbnail

State policymakers can protect American innovation and help Americans live longer, healthier lives

PhRMA

For the second year in a row, life expectancy is on the decline in America. The leading causes of death across the United States include cancer and chronic diseases. Even when patients are able to manage these conditions — e.g., overall cancer survivability has increased 33% since 1991 — their quality of life may still be diminished.

242
242
article thumbnail

4 Attributes of a Great Pharmacy Technician

Pharmacy Tech Scholar

What Makes a Great Pharmacy Technician? Our students commonly ask us for tips on getting a job after completing our PTCB-recognized education program. Being marketable… The post 4 Attributes of a Great Pharmacy Technician appeared first on Pharmacy Tech Scholar.

PTCB 221
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Digital Therapies Poised for Breakthrough in Migraine Treatment

Drug Topics

The number of digital therapeutics available for migraine is likely to expand.

201
201
article thumbnail

Do masks really protect against COVID-19? Meta-analysis authors want to see more evidence

Fierce Healthcare

Do masks really protect against COVID-19?

142
142
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Opinion: Mindstrong’s demise and the future of mental health care

STAT

One of the shinier entrants to have emerged in the world of mental health startups abruptly announced last week it would wind down, right in the middle of an ongoing crisis in mental health care. Mindstrong, which had raised a total of $160 million from a who’s-who of blue-chip investors, and was led for a while by a former National Institute of Mental Health director, simply couldn’t find a way to make money delivering the low-cost, high-quality care it had promised.

137
137
article thumbnail

Black History Month: Pharmacy Trailblazers

Pharmacy Is Right For Me

February marks Black History Month in the United States. We want to take this opportunity to recognize some Black pharmacists who have made significant contributions to the pharmacy field. James McCune Smith James McCune Smith was born into slavery in 1813. He earned his medical degree from Glasgow University. He is recognized as the first African American to earn a medical degree, the first to be published in American medical journals, as well as the first African American to own and operate a

More Trending

article thumbnail

Which payer raked in the most cash last year? The answer likely won't surprise you

Fierce Healthcare

Which payer raked in the most cash last year?

130
130
article thumbnail

Tracking the bird flu, experts see a familiar threat — and a virus whose course is hard to predict

STAT

Veteran influenza epidemiologist Keiji Fukuda remembers vividly when he first became fearful that a virulent bird flu virus, H5N1, might be on the verge of triggering a devastating pandemic. The virus, seemingly out of nowhere, did something bird flu viruses were thought not to be able to do. It infected 18 people, killing six of them. That happened in 1997, in Hong Kong.

136
136
article thumbnail

Vertex pricing under fire—again—as activists press 4 governments for Trikafta generics

Fierce Pharma

Vertex pricing under fire—again—as activists press 4 governments for Trikafta generics fkansteiner Tue, 02/07/2023 - 10:08

124
124
article thumbnail

Is ChatGPT Healthcare's Next Big Thing?

Drug Topics

Artificial intelligence has the potential to revolutionize and improve medicine. However, in order for widespread implementation, certain challenges and obstacles must first be overcome.

201
201
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

CVS Health to acquire Oak Street Health for $10.6B

Drug Store News

CVS Health will acquire Oak Street Health in an all-cash transaction at $39 per share, representing an enterprise value of approximately $10.6 billion.

120
120
article thumbnail

Opinion: The fungal crisis is here and desperately needs addressing

STAT

Fungus-caused infections — real ones, not the ones sparking the zombie apocalypse on the popular show “The Last of Us” — pose a growing threat in the United States and around the world. Mississippi has become the latest state to report residents infected with Candida auris, a highly contagious fungus that thrives in hospitals and nursing homes.

article thumbnail

BREAKING: Bayer taps Roche vet Anderson as its next CEO, pushing out Baumann

Fierce Pharma

BREAKING: Bayer taps Roche vet Anderson as its next CEO, pushing out Baumann esagonowsky Wed, 02/08/2023 - 11:28

119
119
article thumbnail

COVID-19 Omicron Variant Associated with Lower Risk of Severe Illness vs Delta Variant

Drug Topics

Vaccination greatly reduces the probability of experiencing severe COVID-19 in both variants. Adults between the ages of 40 to 59 years saw the most significant reduction in risk when compared to individuals in other age categories.

Vaccines 193
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Scottish biotech aims to cure common cold

Pharmafile

Scottish biotech company ScotBio has announced that it has seen “promising initial results” from its attempts to extract a cure for the common cold from algae. The Livingston-based company is assessing how waste molecules from spirulina, an algae often consumed as a superfood, could be used as a cure for the common cold, COVID-19 and various other viruses.

article thumbnail

STAT+: Bayer, facing investor ire, appoints an outsider CEO

STAT

Bayer named former Roche executive Bill Anderson as its new CEO on Wednesday, potentially ending a dramatic and difficult chapter during which its current chief executive, Werner Baumann, presided over the disastrous $63 billion purchase of the agriculture firm Monsanto. Anderson will take over April 1, becoming the first American to run the 160-year-old conglomerate, which invented aspirin and later played a major role in the development of hormonal contraceptives, hemophilia clotting factors,

121
121
article thumbnail

Five potential EU regulatory changes impacting the life sciences industry in 2023

European Pharmaceutical Review

A wave of important legislative changes is anticipated in the EU in 2023 making this year one of the biggest for the EU regulatory landscape governing the life sciences industry in recent times. Changes have been spurred by the COVID-19 pandemic, which emphasised the need to urgently modernise outdated EU pharmaceutical law and revise regulatory ambitions in the MedTech sector.

Packaging 117
article thumbnail

State of the Union: Drug Prices, Affordable Care, and Cancer A Priority for Biden Administration

Drug Topics

President Biden's 2023 State of the Union address highlighted some key areas of health care in which he hopes to make progress.

187
187
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

How the current economic downturn impacts healthcare funding and investor strategy

Fierce Healthcare

How the current economic downturn impacts healthcare funding and investor strategy agliadkovskaya Fri, 02/10/2023 - 10:37

116
116
article thumbnail

Study suggests DNA sequencing could reduce infant deaths, often caused by genetic disease

STAT

Researchers who believe genomics can transform human health love to recount success stories. They’ll tell you about the 3-month-old boy whose heart was failing until researchers pinpointed what was ailing him. Or the baby girl who could have had a life-threatening reaction to anesthesia had researchers not sequenced her DNA ahead of time. But a new study focuses on a much more somber set of stories: those of infants who died with genetic diseases and who in some cases could have been trea

119
119
article thumbnail

AstraZeneca's Forxiga nabs expanded heart failure approval in Europe

Fierce Pharma

AstraZeneca's Forxiga nabs expanded heart failure approval in Europe zbecker Tue, 02/07/2023 - 14:24

115
115
article thumbnail

COVID-19 Currently A Leading Cause of Death Among Children and Young People

Drug Topics

A 2021 morbidity study found that COVID-19 was among the leading causes of death in children and young people.

187
187
article thumbnail

Albertsons launches app uniting pharmacy, nutrition and telehealth

Fierce Healthcare

Albertsons launches app uniting pharmacy, nutrition and telehealth aburky Fri, 02/10/2023 - 16:29

116
116
article thumbnail

STAT+: 5 health tech startups targeting chronic kidney disease to watch

STAT

There’s been a surge in funding for health tech startups trying to treat or stave off the worst symptoms of chronic kidney disease, a costly and often deadly condition that affects 37 million people in the U.S. alone. Chronic kidney disease develops when the kidneys are so damaged they can’t filter blood as well as needed. People with diabetes, high blood pressure, and other metabolic conditions are at especially high risk of developing the condition.

115
115
article thumbnail

NCPA endorses reintroduction of Senate FTC/PBM bills

Drug Store News

NCPA issued gratitude to Sens. Cantwell and Grassley for their efforts to "pull back the curtain on PBMs and push for FTC review of anticompetitive PBM practices.

106
106
article thumbnail

Assessing Biologic Medications for Effective Management of Severe Asthma in Adults

Drug Topics

The use of biomarker profiles to guide asthma treatment decisions have not been well-studied.

187
187
article thumbnail

DOJ collected nearly $2B in health fraud False Claims Act cases in fiscal year 2022

Fierce Healthcare

DOJ collected nearly $2B in health fraud False Claims Act cases in fiscal year 2022 rking Wed, 02/08/2023 - 16:01

116
116
article thumbnail

Opinion: Pregnant people with substance use disorders need treatment, not criminalization

STAT

Though it may be hard for many to fathom, even pregnant people and new parents can have active substance use disorders. They need support, not criminalization. The addiction and overdose crisis, which now claims more than 100,000 lives a year , shows little sign of abating, and emerging data highlight its startling impact on pregnant people: Overdose is now a leading cause of death during or shortly after pregnancy.

111
111
article thumbnail

CVS Health posts strong Q4, full-year 2022 results

Drug Store News

CVS Health’s fourth quarter revenues increased to $83.8 billion up 9.5% compared to the prior year.

106
106
article thumbnail

Can Patient-Centered Prescription Labels Increase Medication Adherence?

Drug Topics

Researchers evaluated how changes in USP labeling standards have affected adherence across multiple classes of drugs.

Labelling 186
article thumbnail

HHS releases new guidance implementing key Medicare drug rebate program

Fierce Healthcare

HHS releases new guidance implementing key Medicare drug rebate program rking Thu, 02/09/2023 - 16:01

111
111
article thumbnail

Seizure drug offers hope of expanding the pool of donor hearts

STAT

The moment a donor heart is cut off from its blood supply, transplant teams are on a race against the clock to remove it, transport it, and sew it into the recipient, all within four hours. A new way of reprogramming donor hearts could give them more time. A study published Wednesday in Science Translational Medicine finds that when valproic acid, a medication to treat seizures, is infused in donor hearts, it could significantly extend — potentially double — the safe storage time o

111
111
article thumbnail

Astellas and Bayer announce management changes

European Pharmaceutical Review

Changes to management for Big Pharma companies Astellas and Bayer AG have been announced for 2023. Astellas Astellas Pharma Inc. has approved changes of its Representative Director, President and CEO and its management structure. Effective April 1, 2023, Naoki Okamura and Kenji Yasukawa will hold the following positions: Naoki Okamura is currently Representative Director, Executive Vice President of Astellas.

105
105